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b-dystroglycan (DG) and thedystrophin-glycoprotein
complex (DGC) are localized at costameres and neu-
romuscular junctions in the sarcolemma of skeletal
muscle. We present evidence for an ankyrin-based
mechanism for sarcolemmal localization of dystro-
phin and b-DG. Dystrophin binds ankyrin-B and
ankyrin-G, while b-DG binds ankyrin-G. Dystrophin
and b-DG require ankyrin-G for retention at costa-
meresbut not delivery to the sarcolemma.Dystrophin
and b-DG remain intracellular in ankyrin-B-depleted
muscle, where b-DG accumulates in a juxta-TGN
compartment. The neuromuscular junction requires
ankyrin-B for localization of dystrophin/utrophin
and b-DG and for maintenance of its postnatal mor-
phology. A Becker muscular dystrophy mutation
reduces ankyrin binding and impairs sarcolemmal
localizationofdystrophin-Dp71.Ankyrin-Balsobinds
to dynactin-4, a dynactin subunit. Dynactin-4 and a
subset of microtubules disappear from sarcolemmal
sites in ankyrin-B-depleted muscle. Ankyrin-B thus
is an adaptor required for sarcolemmal localization
of dystrophin, as well as dynactin-4.
INTRODUCTION
The absence of dystrophin in Duchenne muscular dystrophy is
accompanied by failure in accumulation of dystroglycan and
other components of the dystrophin-glycoprotein complex
(DGC) at the sarcolemma (Cohn and Campbell, 2000; Dalkilic
and Kunkel, 2003; Ervasti et al., 1990). The DGC is enriched in
costameres, which are specialized domains formed at the junc-
tion of the plasmamembrane and Z discs of peripheral myofibrils
(Bloch et al., 2004; Ervasti, 2003; Pardo et al., 1983; Rybakova
et al., 2000). Dystrophin and its homolog utrophin form similar
complexes that localize to the postsynaptic membrane of the
neuromuscular junction (NMJ). b-dystroglycan (b-DG) is the
core membrane-spanning component of the DGC, which
connects the actin cytoskeleton to the extracellular matrix inCskeletal muscle (Lapidos et al., 2004; Rybakova et al., 2000).
b-DG also is targeted to NMJs where it links intracellular proteins
(dystrophin, utrophin, dystrobrevin, rapsyn) to laminin and agrin
in the ECM and is required for postnatal maturation of the post-
synaptic membrane (Grady et al., 2000; Sanes and Lichtman,
1999).
The cellular mechanisms underlying the role of dystrophin in
localization of the DGC in skeletal muscle remain to be resolved.
Dystrophin associates with members of the syntrophin family,
which recruit NOS and aquaporin 4 but are not required for asso-
ciation of dystrophin with the sarcolemma (Adams et al., 2001).
Several considerations suggest that the ankyrin family of adap-
tors may play a role in organization of the DGC. Ankyrin-B
(ankB) and ankyrin-G (ankG) are localized at costameres (Hopit-
zan et al., 2005; Nelson and Lazarides, 1984; Tuvia et al., 1999;
Williams et al., 2001), while ankG is a component of the neuro-
muscular junction (Kordeli et al., 1998). Moreover ankB and
ankG function in organization of diverse bilayer-spanning pro-
teins in specialized membrane domains (Bennett and Healy,
2008). We report here that ankB and ankG both bind to dystro-
phin and have distinct roles in organization of dystrophin and
b-DG in the sarcolemma. AnkG binds b-DG as well as dystrophin
and is required to restrict b-DG and dystrophin at costameres.
We demonstrate that ankyrin-dependent organization of sarco-
lemmal dystrophin and b-DG is required for sarcolemmal integ-
rity during physical exercise. Both dystrophin and b-DG remain
intracellular in ankB-depleted muscle. We also demonstrate
that ankB binds to dynactin-4 (also known as the p62 subunit
of the dynactin complex), which has been proposed to function
in connecting the dynactin complex to membrane sites (Eckley
et al., 1999), and show that ankB is required for sarcolemmal
localization of dynactin-4 as well as a specialized class of micro-
tubules. AnkB thus is an adaptor for dystrophin, as well as
dynactin-4.
RESULTS
Loss of Sarcolemmal DGC in Neonatal AnkB/ Muscle
AnkB/ mice have elevated serum creatine kinase, suggesting
a congenital myopathy (Tuvia et al., 1999). We initially attributed
this skeletal muscle myopathy to abnormalities in calcium ho-
meostasis since ankB/ neonatal cardiomyocytes exhibitedell 135, 1189–1200, December 26, 2008 ª2008 Elsevier Inc. 1189
Figure 1. AnkB Is Required for Sarcolem-
mal Dystrophin and b-DG
(A) DGC proteins are mislocalized in neonatal
ankB/ muscle. Quadriceps cross-sections
from P0 wild-type and ankB/ mice were labeled
with antibodies against ankB, ankG, dystrophin,
b-DG, and a-actinin. Sarcolemmal staining of dys-
trophin and b-DG is markedly reduced in ankB/
fibers while ankG and a-actinin show normal stain-
ing. Total of 6–8 pups per genotype, bar = 10 mm.
(B) Expression of ankG, dystrophin, and b-DG in
wild-type and ankB/ is identical in immunoblots
of skeletal muscle.
(C) In isolated adult tibialis anterior (TA) fibers,
ankB colocalizes with g-actin in costameres.
(D) Transfection of adult muscle with a plasmid
encoding ankB-siRNA knocks down ankB but
not ankG or g-actin.
(E) Dystrophin and b-DG are markedly reduced in
the sarcolemma of ankB-depleted muscle fibers
but not in fibers cotransfected with plasmids
encoding both siRNA and GFP-tagged human
ankB (hankB-GFP) (green), which is resistant
to mouse siRNA. (N = 4 individual experiments,
n = 2 mice per experiment, total of 8 mice. Scale
bar, 5 mm.)
(F) EBD (red) penetrates specifically ankB-
depleted (-ankB) fibers but not those transfected
with Venus vector lacking siRNA inmice subjected
to exercise. Fibers transfected with the ankB-
siRNA plasmid are identified by Venus expression
(green). Muscles cotransfected with plasmids en-
coding both ankB siRNA and human ankB do not
take up EBD. Sarcolemma (white) is marked by
ankG staining. N = 4 experiments, n = 3 mice per
experiment per genotype (total of 27 mice, 9 per
genotype). Bar = 20 mm.
(G) b-DG accumulates in and outside the TGN
(marked by golgin 97) in ankB-depleted fibers. Im-
ages are 3D reconstructions of Z series comparing
control and ankB-depleted fibers for colocaliza-
tion of b-DG and golgin 97.
(G0) In control fibers, 89% ± 6% of the b-DG over-
laps with the TGN. In ankB knockdown fibers,
50% ± 7% of the b-DG overlaps with the TGN
while the rest accumulates next to and outside of
the TGN (50 individual TGN site were measured
for each control and ankB-siRNA in multiple fibers
from 3 animals each. Significance of difference be-
tween control and ankB-siRNA measurements
was calculated using one-way ANOVA, p = 0).abnormal calcium dynamics (Tuvia et al., 1999). Subsequent
studies have revealed that elevated calcium transients in ankB-
deficient cardiomyocytes result from loss of a complex of ankB
with the Na/Ca exchanger, Na/K ATPase, and IP3R (Mohler
et al., 2003, 2005). However, this ankB-based complex is a spe-
cific adaptation of cardiomyocytes and is not present in skeletal
muscle (Mohler et al., 2005). We therefore tested whether ab-
sence of ankB in neonatal mice affected localization of DGC pro-
teins in skeletalmuscle.Cross-sections of quadricepsmuscles of
newborn ankB null mice were immunolabeled for dystrophin and1190 Cell 135, 1189–1200, December 26, 2008 ª2008 Elsevier Inc.b-DG. Strikingly, labeling for these proteins is markedly reduced
in the plasma membrane of ankB/ muscle fibers (Figure 1A).
Note that costameres (only 2 microns apart) appear as a solid
line when viewed in these 20-micron-thick tissue sections.
Ankyrin-G (ankG) and the Z line protein a-actinin are normally
localized in ankB/ muscle. Protein levels of the above DGC
proteins in ankB null muscle are identical to wild-type levels in
immunoblots (Figure 1B). Together, these findings suggest a
specific defect in either delivery to or maintenance of dystrophin
and b-DG in the sarcolemma in ankB/ muscle.
Loss of Sarcolemmal Dystrophin and b-DG
in Adult AnkB-Depleted Muscle
AnkB is expressed in most tissues, including the nervous
system, and ankB null mice die soon after birth. These consider-
ations suggested the possibility of an indirect effect of ankB de-
ficiency on neonatal skeletal muscle. In order to study the role of
ankB specifically in adult muscle of otherwise healthy animals,
we knocked down ankB in skeletal muscle of adult mice using
siRNA. We transfected tibialis anterior (TA) muscles of adult
mice by electroporation with a bicistronic plasmid encoding
a mouse-specific ankB-siRNA and Venus as a fluorescent
marker for transfected fibers (Experimental Procedures). Muscle
fibers were subsequently isolated and costamere proteins visu-
alized in grazing sections by confocal microscopy. Figure 1C
demonstrates sarcolemma-associated ankB in costameres,
precisely colocalizing with g-actin as a marker. Figure 1D shows
the effective knockdown of ankB expression following siRNA
expression, while g-actin and ankG remain intact. Control fibers
transfected with the Venus vector showed normal expression
and distribution of b-DG, dystrophin, ankyrins-B and –G, as
well as spectrin and vinculin (data not shown). Strikingly, ankB-
depleted fibers exhibited marked reduction of both dystrophin
and b-DG in the sarcolemma (Figure 1E). In contrast, g-actin
and ankG (Figure 1D) as well as spectrin and vinculin (data not
shown) exhibited an unaltered labeling pattern. AnkB-depleted
costameres thus are structurally intact but are selectively miss-
ing b-DG and dystrophin.
Loss of b-DG and dystrophin was prevented by cotransfection
with cDNA encoding human ankB that was resistant to mouse
siRNA (Figure 1E). In rescue experiments, mice were transfected
in one leg with an ankB siRNA-expressing plasmid and in the
other with ankB siRNA plus cDNA encoding GFP-tagged human
ankB. Human ankB-GFP staining, overlaying the diffuse Venus
staining (marking siRNA-expressing fibers), is distributed in
a costamere pattern indistinguishable from endogenous ankB.
Dystrophin and b-DG are clearly present and properly enriched
in costameres of rescued fibers. These experiments establish
that ankB is required for the presence of b-DG and dystrophin
at the sarcolemma of adult muscle.
We next tested whether ankB knockdown results in sarcolem-
mal fragility. TA muscles were transfected with ankB-siRNA in
the bicistronic Venus vector with and without cotransfection
with a plasmid encoding human ankB-GFP for rescue as de-
scribed above. As a control we injected muscles with the Venus
vector alone. Mice were exercised on a treadmill and injected IP
with Evans Blue Dye (EBD), which penetrates damaged fibers
(Straub et al., 1997). To insure that muscle samples evaluated
for EBD uptake were representative, we cross-sectioned
throughout the entire muscle length at 200 mm intervals (approx-
imately 30 sections per muscle). Fibers expressing only the
Venus control plasmid exhibited no EBD uptake (Figure 1F).
However, fibers expressing ankB siRNA (about 80% based on
coexpression of Venus) exhibit EBD penetration. Cotransfection
with plasmids encoding mouse ankB-siRNA and human ankB-
GFP prevented EBD uptake. Images in Figure 1F are representa-
tive of sections taken from 12 muscles (6 mice) each of control,
knockdown, and rescued animals in two different exercise/
transfection experiments. In contrast to the MDX mouse andother animal models where EBD dye uptake is variable (Straub
et al., 1997), all of the fibers transfected with ankB siRNA also
exhibited EBD uptake. A likely difference between acute
siRNA-mediated depletion and genetic mouse models is that
in the former, upregulation of utrophin and other compensatory
mechanisms do not occur. AnkB thus is required for sarcolem-
mal localization of b-DG and dystrophin in adult skeletal muscle
and to maintain structural integrity of muscle challenged by
exercise.
We demonstrate below that ankB depletion also has substan-
tial effects on the postnatal NMJ. To determine if the phenotype
observed in siRNA knockdown fibers is a result of loss of neuro-
nal input, we evaluated effects of blocking neurotransmission by
local injection with fluorescently labeled a-bungarotoxin (aBgt),
which irreversibly inactivates nicotinic acetylcholine receptors
(nAChR). Individual TA muscles were injected daily with aBgt
(0.11 mg/g, half the LD50 for the whole mouse; Windholz, 1983)
for 3 consecutive days (Supplemental Experimental Procedures
available online). We observed no difference between control
and aBgt-treated fibers in terms of b-DG localization in costa-
meres, as well as in the general morphology of the NMJ
(Figure S1).
b-DG Accumulates in an Intracellular Compartment
in AnkB-Depleted Muscle
We next sought to determine the fate of b-DG and dystrophin in
ankB-depleted adult muscle. Immunoblots revealed no reduc-
tion of b-DG and dystrophin polypeptides, even though ankB
was markedly reduced in these siRNA-treated muscles (data
not shown). These results recapitulated the preservation of these
proteins in ankB null neonatal muscle (Figure 1B) and suggested
that b-DG and/or dystrophin may accumulate in an intracellular
compartment. We could not detect dystrophin in ankB-depleted
muscle by immunofluorescence under a variety of fixation condi-
tions. However, intracellular b-DG could be visualized in discrete
micron-sized loci in both wild-type and ankB-depleted fibers
permeabilized with saponin. b-DG-labeled puncta did not cola-
bel with the endosomal marker Rab11 in either wild-type or
ankB-depleted fibers. However, b-DG staining in control muscle
colocalized with the trans-Golgi network (TGN) marker golgin 97
(Figure 1G). Voxel measurements derived from Z stacks reveal
89% (±6%, n = 50 golgi sites) overlap of b-DG labeling with
golgin 97, while the remaining 11% b-DG staining was closely
associated with the TGN (Figure 1G0). In contrast, only 50% ±
7% of b-DG staining in ankB-depleted fibers overlaps with the
TGN (Figure 1F0), while the remaining 50% of b-DG staining is
close to, but distinct from, the TGN. The difference in extra-
TGN staining of b-DG of 50% in ankB-depleted fibers compared
to 11% in controls was highly significant, with p = 0 in one-way
ANOVA. Interestingly, the percent overlap between intracellular
b-DG and golgin 97 is the same at high magnification and at
lower magnification covering multiple sarcomeres for both
wild-type and ankB-depleted fibers. Thus intracellular b-DG is
primarily associated with or near the TGN, at least under these
experimental conditions of fixation and permeabilization. In
summary, dystrophin and b-DG are not degraded in ankB-
depleted fibers, and b-DG accumulates in a juxta-TGN compart-
ment distinct from rab11-labeled endosomes.Cell 135, 1189–1200, December 26, 2008 ª2008 Elsevier Inc. 1191
Figure 2. AnkG Is Required for Restriction of Dystrophin and b-DG at Costameres and for Sarcolemmal Integrity
(A) AnkG colocalizes with g-actin in costameres of isolated muscle fibers.
(B) AnkG-siRNA knocks down ankG but not ankB or g-actin.
(C) Loss of costamere localization of dystrophin and b-DG in the sarcolemma of ankG-depleted muscle fibers, but not fibers cotransfected with plasmids encod-
ing both ankG siRNA and GFP-tagged rat ankG resistant to mouse siRNA (rankG-GFP).
(C0 and C00) Optical sections through the sarcolemma of b-DG and dystrophin-stained fibers. Punctate costameres are replaced by continuous sarcolemmal
labeling following ankG depletion (N = 3, n = 7).
(D) EBD (red) penetrates specifically ankG-depleted (-ankG) fibers but not those cotransfected with plasmids encoding both ankG siRNA and GFP-tagged rat
ankG resistant to mouse siRNA (rankG-GFP) in mice subjected to exercise. Sarcolemma marked in white by bDG staining. N = 3, n = 3 mice per experiment
per genotype (total 27 mice). Bars = 5 mm.AnkG Retains b-DG and Dystrophin at Costameres
Ankyrins-B and -G are closely related in their membrane-binding
and spectrin-binding domains and are coexpressed in cardio-
myocytes as well as other cells. However, these ankyrins are
highly divergent in their C-terminal domains, which function in
intramolecular regulation, and have distinct cellular roles (Abdi
et al., 2006). AnkG is localized in costameres and colocalizes
with g-actin (Figure 2A) (Hopitzan et al., 2005; Williams et al.,
2001). We used the same siRNA knockdown strategy as for
ankB to test whether ankG has a role in localization of b-DG
and dystrophin. Figure 2B demonstrates effective ankG knock-
down while ankB and g-actin remain intact. Localization of1192 Cell 135, 1189–1200, December 26, 2008 ª2008 Elsevier Inc.ankB and ankG in costameres thus is independent of each
other’s expression. As shown in Figure 2C, in the absence of
ankG, b-DG and dystrophin are present in the sarcolemma.
However, their costamere pattern is lost, and they are diffusely
distributed throughout the sarcolemma. An optical section along
the longitudinal axis through the sarcolemma shows that instead
of the punctate costamere pattern in normal fibers, the staining
patterns of b-DG and dystrophin in ankG-depleted fibers are
continuous (Figures 2C0 and 2C00, respectively). A costamere
pattern of dystrophin and b-DG is preserved by introducing
GFP-tagged rat ankyrin-G that is resistant to the mouse-specific
ankG siRNA (Figure 2C).
We repeated the exercise experiment with mice transfected
with ankG siRNA, both with and without rescue with rat ankG-
GFP (same experimental procedure as described above for
ankB-siRNA). AnkG-depleted muscle fibers exhibit uptake of
EBD when subjected to physical exercise and can be rescued
by introducing rat ankG-GFP (Figure 2D). Thus muscle fiber in-
tegrity not only depends on the presence of b-DG and dystrophin
in the sarcolemma but may also require that these proteins are
specifically retained at costameres by ankG.
Ankyrins Act upstream of Dystrophin
We next asked whether localization of ankyrins-B and-G at cos-
tameres is dependent on dystrophin and b-DG. We evaluated
wild-type and dystrophin-deficient mdx mice that were 4 to
6 weeks old.Mdxmice at this age have previously been reported
to express only residual levels of utrophin and b-DG in skeletal
muscle (Roma et al., 2004). In Figure 3A we show in cross-
sections that dystrophin/utrophin (the dystrophin antibody
used crossreacts with utrophin) are absent and b-DG is missing
from the mdx sarcolemma. However, ankyrins-B and -G show
sarcolemmal labeling in cross-sections that is indistinguishable
from wild-type muscles. Figure 3B further demonstrates that an-
kyrins-B and -G properly localize at costameres in isolated fibers
from mdx muscle and colocalize with g-actin. AnkB and ankG
therefore localize at costameres independently from dystrophin
and dystroglycan.
Figure 3. Costamere Localization of AnkB and
AnkG Is Independent of Dystrophin and b-DG
(A) Cross-sections of 4- to 6-week-old wild-type and
mdx TAmuscles were stained and compared for pres-
ence of dystrophin (antibody also crossreacts with
utrophin), b-DG, ankB, and ankG using identical image
acquisition settings. While dystrophin/utrophin and
b-DG show no or residual sarcolemmal staining,
both ankyrins label mdx sarcolemma as they do in
wild-type muscle (bar = 20 mm).
(B) Grazingoptical sectionsof isolatedmdxfibers verify
not only that ankyrins-B and -G are expressed in mdx
sarcolemma, but also that they are properly localized
at costameres, colocalizing with g-actin (bar = 5 mm).
Loss of Dystrophin and b-DG
in AnkB-Depleted Postnatal NMJs
The neonatal neuromuscular junction de-
velops extensive branches and in-foldings
during the first few weeks after birth (Sanes
and Lichtman, 1999). b-DG, dystrophin,
and utrophin are enriched in the postsynap-
tic membrane of the NMJ (Grady et al., 2000;
Sanes and Lichtman, 1999) and are required
for postnatal differentiation of the NMJ (Cote
et al., 1999; Grady et al., 2000). In Figure 4A
we show that ankB localizes at adult NMJs,
where it forms a ‘‘foot print’’ layer under-
neath the NMJ boundaries marked by
fluorescently labeled a-bungarotoxin (aBgt).
We therefore evaluated the role of ankB in
localization of b-DG, dystrophin, and utrophin at neonatal and
adult NMJs.
In ankB/ neonatal NMJs, b-DG is still present at the NMJ
despite the absence of staining for b-DG in the rest of the sarco-
lemma (Figure S2A) and lack of NMJ staining for dystrophin/
utrophin (Figure S2B). Evidently, accumulation of b-DG at the
neonatal NMJ does not require either ankB or dystrophin/
utrophin. At this neonatal stage, the general morphology of the
neonatal NMJ, as revealed by aBgt, is identical in wild-type
and ankB/ mice (determined by 3D reconstruction of Z series
of NMJs taken on isolated fibers, not shown).
We next assessed localization of b-DG and dystrophin/utro-
phin at the NMJ in muscles of adult mice treated with ankB
siRNA, as described above. The NMJ of ankB-siRNA-treated
muscles exhibit dramatic loss of both b-DG (Figure 4B) and
dystrophin/utrophin (Figure 4C). Moreover, the typical pattern
of nAChRs marked by aBgt is replaced by an amorphous blur
(Figures 4B and 4C) resembling the diminished NMJs observed
in dystroglycan-deficient mice (Cote et al., 1999). Three-dimen-
sional images show the dramatic deformation and neonatal ap-
pearance of the adult NMJmorphology following ankB depletion
(Figure 4D). Wewere unable to deplete ankG from the NMJ using
the same protocol that was effective in knocking down ankG at
costameres. AnkG apparently is too stable at the NMJ for this
type of siRNA-based knockdown. In summary, in the absence
of ankB, dystrophin, utrophin, and b-DG are missing from theCell 135, 1189–1200, December 26, 2008 ª2008 Elsevier Inc. 1193
Figure 4. Loss of Dystrophin and b-DG in AnkB-Depleted Postnatal
NMJs
(A) AnkB (red) is localized at the postnatal NMJ marked by aBgt (green); 3D
image is shown (Experimental Procedures).
(B and C) b-DG (B, red) and dystrophin/utrophin (C, red) are absent from the
NMJ in ankB-siRNA-treated fibers. aBgt (green) labels AChRs. Note disrupted
morphology of the mature NMJ.
(D) Three-dimensional images of aBgt-labeled NMJs of wild-type adult (left),
ankB-depleted adult (middle), and neonatal wild-type muscle. All images in
(D) are to scale. Bars = 5 mm.1194 Cell 135, 1189–1200, December 26, 2008 ª2008 Elsevier Inc.postsynaptic NMJmembrane, and the whole structure reverts to
a neonatal morphology.
Dystrophin-Dp71 Binds AnkB and AnkG
while b-DG Binds AnkG
Next we addressed potential protein interactions of ankyrins-B
and -G underlying localization of dystrophin and b-DG. Neither
ankyrin was effectively solubilized following published protocols
for DGC isolation (data not shown), which explains why no
ankyrin was noted as stoichiometric components of the DGC
isolated from skeletal muscle (Campbell and Kahl, 1989). Identi-
fication of ankyrin partners by coimmunoprecipitation therefore
was not feasible. We adopted a candidate gene approach and
performed in vitro binding assays evaluating interactions of
ankB and ankG with either dystrophin-Dp71 or the cytoplasmic
tail of b-DG, both fused to GST and immobilized on glutathi-
one-sepharose beads. Dystrophin-Dp71 is a naturally occurring
dystrophin variant lacking the first 62 exons encoding the actin-
binding and rod domain but retaining the cysteine-rich/C-termi-
nal domain as well as activity in targeting the DGC to costameres
(Cox et al., 1994).
Both ankB and ankG bind directly to GST-dystrophin-Dp71
(Figure 5A). Moreover, ankG also associates with the GST-
tagged cytoplasmic tail of b-DG, although ankB does not
(Figure 5A). Controls included no binding to GST alone and no
binding of Dp71 and the cytoplasmic tail of b-DG to ankyrins
denatured by diethyl pyrocarbonate (data not shown). To identify
the ankyrin-binding region in dystrophin-Dp71, we tested the N0
and the C0 termini halves of Dp71 for ankyrin binding in vitro.
The junction between amino acids Q359/L360 of Dp71 was cho-
sen based on a prediction of a transition point between a struc-
tured N-terminal region and an unstructured C-terminal region
(http://iupred.enzim.hu/Theory.html; see Experimental Proce-
dures). In Figure 5Bwe show that ankB binds only the N-terminal
portion of Dp71, corresponding to exons 63–72 of the full-length
dystrophin gene (Dp427) and containing the cysteine-rich do-
main. The same result was obtained for ankG (data not shown).
We next mapped the ankG-binding site of b-DG. We tested
a series of deletion mutants in the cytoplasmic domain of b-DG
(DGcyto), described in Figure 5C, for binding to ankG in vitro.
As described in Figure 5D, a 33 amino acid membrane-proximal
region, DGcytoD810-895, bound ankG to the same extent as the
whole cytoplasmic domain. A deletion mutant, DGcytoD776-
809, lacking the membrane-proximal residues, did not bind
ankG. Point mutations in the proximal region of the full-length
cytoplasmic domain further defined the binding site. Two muta-
tions, IIF798AAA and DE802AA, show loss of binding to ankG
down to almost background levels, while a third mutant,
DD805AA, shows a major reduction. Other mutants exhibited
normal binding. The ankG-binding site of b-DG thus is localized
to 10 amino acids located adjacent to the membrane-bilayer-
spanning region. The ankG-binding site is distinct from the
reported binding site for dystrophin located at the C terminus
of b-DG (Jung et al., 1995).
We next evaluated whether b-DG could bind to Dp71 in the
presence of ankB or ankG. Assays with GST-tagged Dp71
revealed no effect of either ankB or ankG on binding of the b-DG
cytoplasmic domain (GST removed by procission protease)
Figure 5. Dp71 Binds AnkB and AnkG, and b-DG Binds AnkG In Vitro
(A) Coomassie blue gel shows (left) input of purified proteins. On right, binding assays show that immobilized GST-Dp71 binds ankyrins-B and-G. GST-b-DG
cytoplasmic domain binds only ankG.
(B) Ankyrin-B binds the structured N0-terminal half of dystrophin-Dp71. Junction between the N0-terminal Dp71 section (Dp71N0, red) and the C0-terminal section
(Dp71C0, green) was designed based on a prediction of transition from a structured to an unstructured section of Dp71 (see Results for details). Purified
GST-fusion proteins of either full-length Dp71, Dp71N0, or Dp71C0 were tested for binding to ankyrin-B (shown) and ankyrin-G (not shown). Coomassie blue
gel shows that only the N0-terminal region of Dp71 binds ankyrin-B.
(C and D) GST-tagged b-DG cytoplasmic domain binds ankG in a juxta-membrane region. (C) Truncations andmutations tested for identification of ankG-binding
region. (D) AnkG binding to constructs described in (C). All constructs are His tagged and visualized using anti-His antibody. All bands are from one original
immunoblot but cropped for clearer presentation.(Figure S3). Therefore, dystrophin can form a ternary complex
with b-DG and either ankG or ankB.
A Becker MD Mutation Impairs AnkB Binding
and Localization of Dp71
We identified in the Leiden Muscular Dystrophy (MD) database
nine missense mutations located in the N-terminal ankyrin-bind-
ing domain of dystrophin-Dp71 that have been reported to cause
either Duchenne or Becker muscular dystrophies in human
patients (Aartsma-Rus et al., 2006). We introduced eight of
these mutations into full-length dystrophin-Dp71 and assessed
their effect on binding to ankyrins-B and -G. The mutationAsp3335Asn, which was reported in Becker MD (equivalent to
Asp267Asn in dystrophin-Dp71), reduces the binding of dystro-
phin-Dp71 to both ankB (Figures 6A and 6B) and ankG (data not
shown) by 50%.
We next evaluated the effect of the Asp267Asn mutation of
Dp71 on its localization in skeletal muscle. We transfected TA
muscles in vivo with either an HA-tagged Dp71 or the HA-tagged
Dp71 Asp267Asn. Both wild-type and mutant Dp71 were ex-
pressed at equivalent levels based on immunoblots of trans-
fected muscle using HA antibody (data not shown). Transfected
fibers were identified by cotransfection with a Venus plasmid in
a 1:10 ratio in favor of Dp71, and only Venus-expressing muscleCell 135, 1189–1200, December 26, 2008 ª2008 Elsevier Inc. 1195
fibers were examined. In Figure 6Ca, we demonstrate using an-
tibody against the HA epitope that HA-tagged wild-type Dp71
does target to costameres. In contrast, mutated Dp71 (Dp71mut)
exhibited two abnormal localization phenotypes. Approximately
70%–80% of the transfected fibers did not show any sarcolem-
mal labeling for HA-Dp71mut (Figure 6Cb). In theminority of fibers
that did show sarcolemmal staining, the Dp71mut distribution is
amorphous, while endogenous b-DG in the same fibers shows
normal costamere localization (Figure 6Cc). These results are
consistent with a requirement for Dp71 interaction with ankB
for its localization at the sarcolemma and with ankG for retention
of Dp71 at costameres.
Costamere-Associated Microtubules Require AnkB
Muscle contains a subset of microtubules associated with the
sarcolemma and aligned with costameres (Boudriau et al.,
1993). Moreover, ankB binds to microtubules in vitro (Bennett
and Davis, 1981; Davis and Bennett, 1984). We therefore won-
dered if costamere-associated microtubules depend on ankB.
Colabeling for ankB and a-tubulin in control fibers reveals that
a-tubulin overlaps at costameres with ankB (Figure 7A). Strik-
ingly, costamere-associated microtubules disappear in ankB-
depleted fibers, while longitudinal microtubules are unaffected
(Figure 7B). Three-dimensional images further resolve the costa-
mere-associated subset of microtubules, which form transverse
rings exclusively at the circumference of the fiber (Figure 7A0).
Deeper intracellular microtubules are parallel to the fiber axis,
running along the myofibrils (Figure 7A00). AnkB-depleted fibers
Figure 6. A Becker MD Mutation (Asp267Asn) in Dys-
trophin Dp71 Impairs Ankyrin Binding and Dystrophin
Dp71 Localization in Skeletal Muscle
(A) Mutations *1, *2, *3 in positions 251, 267, 328 of Dp71
correspond to human MD mutations Cys3319Arg (T9955C),
Asp3335Asn (G10003A), Pro3396Ser (C10186T) in full-length
dystrophin Dp427, respectively.
(B) GST-Dp71 Asp267Asn (Dp71mut) has 50% reduction in
binding to ankB (shown) and ankG (not shown) (Experimental
Procedures). Molar ratios of ankB bound to GST-Dp71 pro-
teins were determined in six separate experiments presented
in the bar graph (***p = 0, Student’s t test). Bars, from left to
right: mutation *1: 96.3 ± 4.6; mutation *2: 50.3 ± 5.9; mutation
*3: 90.0 ± 10.9.
(C) Mislocalization of Dp71mut in transfected muscle fibers.
(Ca) HA-tagged wild-type Dp71 (detected with HA antibody)
(red) localizes to costameres overlapping the endogenous
b-DG (green). (Cb) Most fibers transfected with HA-Dp71mut
(red) (*2 panels A and B) show no membrane localization.
(Cc) In a minority of fibers, HA-Dp71mut does localize to the
sarcolemma but fails to localize at costameres (marked by en-
dogenous b-DG). Venus expression identified the transfected
fibers. Scale bars, 5 mm.
entirely lose the costamere-associated microtu-
bules while retaining intracellular longitudinal mi-
crotubules (Figures 7B0 and 7B00). In contrast to
ankB, ankG-depleted fibers exhibit normal staining
of both microtubule populations (data not shown).
A network of microtubules surrounding mature
NMJs is closely associated with the plasma mem-
brane (Figure S4A). In Figure 4 we show that ankyrin-B underlies
the NMJ. In Figure S4Bwe show that the NMJ-associatedmicro-
tubules are lost in ankB-siRNA treated fibers, while in the same
fiber the deeper longitudinal microtubules remain (Figure 7B0).
These experiments demonstrate that ankB is required for forma-
tion and/or stability of a special subset of microtubules associ-
ated with costameres and neuromuscular junctions.
Dynactin-4 Binds AnkB and Requires AnkB
to Localize at Costameres
A yeast two-hybrid screen using a heart cDNA library identified
dynactin-4 (dyn4/p62) as a potential ankB-interacting protein
(data not shown). Dyn4/p62 is associated with the pointed end of
the dynactin complex and has been predicted to connect dynein
tomembrane proteins (Schroer, 2004). To test whether ankB and
dyn4/p62 associate in solution, we expressed dyn4/p62 as a
GST-fusion protein and performed binding assays with purified
ankB. In Figure 7C we show that ankB binds to GST-dyn4/p62
with high affinity with a dissociation constant (KD) of 50 nM. We
generated a specific dyn4/p62 antibody to visualize dyn4/p62
inmuscle fibers. In Figure 7D,we show that in adultmuscle fibers,
dyn4/p62 is localized in a punctatemanner along costamere lines
overlapping with costamere ankB (71% overlap). p50 and
p150Glued, two additional subunits of the dynactin complex,
also show identical costamere-associated punctate staining as
dyn4/p62 (data not shown). Strikingly, costamere-associated
dyn4/p62 disappears in ankB-depleted fibers (Figure 7D). In
summary, ankB is required for the costamere localization of1196 Cell 135, 1189–1200, December 26, 2008 ª2008 Elsevier Inc.
Figure 7. Costamere-Associated Microtubules and dyn4 Disappear in AnkB-Depleted Skeletal Muscle
(A) Tubulin staining (green) overlaps with costamere ankB (red).
(B) In ankB-depleted fibers transverse microtubules disappear while longitudinal microtubules remain.
(A0 and B0) Three-dimensional images show transverse costamere-associated microtubules at the circumference of the fiber of wild-type (A0) that are missing in
ankB-depleted fibers (B0).
(A00 and B00) Same 3D images rotated 180 along their long axis to reveal deeper longitudinal microtubules, parallel to the axis of the fiber present in both wild-type
and ankB-depleted fibers.
(C) Curve of purified proteins ankB and GST-dyn4 binding in vitro demonstrate a KD of 50 nM.
(D) In control fibers dyn4 demonstrates a punctate distribution along costameres, marked by ankB (both low and high magnification). In ankB-depleted fibers dyn4
staining is lost.dyn4/p62 and is a candidate to mediate interactions of dyn4/p62
with membrane cargo as well as to stabilize the fast-growing
ends of specialized microtubules associated with costameres.
DISCUSSION
We present evidence for an ankyrin-based pathway required
for sarcolemmal localization of dystrophin and b-DG and forCresistance of skeletal muscle to exercise-induced injury as well
as maintenance of the postnatal NMJ. The dystrophin cyste-
ine-rich domain binds ankB and ankG, while the cytoplasmic do-
main of b-DG binds to ankG through residues distinct from its
dystrophin-binding site. Moreover, dystrophin and b-DG require
ankB for their sarcolemmal localization and require ankG for their
retention at costameres. Skeletal muscle depleted of either ankB
or ankG by siRNA exhibited increased fragility followingell 135, 1189–1200, December 26, 2008 ª2008 Elsevier Inc. 1197
exercise, and this was prevented by cotransfection of siRNA-re-
sistant versions of the corresponding ankyrins. The NMJ also
requires ankB for localization of dystrophin/utrophin and b-DG
as well as for maintenance of its postnatal morphology. Interest-
ingly, ankB depletion and dystroglycan depletion both had sim-
ilar effects on the postnatal NMJ (Cote et al., 1999). We identified
in the Leiden MD database a Becker muscular dystrophy muta-
tion that reduces binding of dystrophin-Dp71 to ankB and ankG
and impairs sarcolemmal localization of dystrophin-Dp71. These
observations establish that ankB and ankG together are essen-
tial for localization and function of dystrophin and b-DG
in skeletal muscle.
Dystrophin and utrophin complexes have been implicated in
postnatal maturation of the NMJ, which develops elaborate
branching in the weeks after birth. One explanation for localiza-
tion of DGCproteins at the NMJ has been regulated transcription
at the subsynaptic nuclei (Sanes and Lichtman, 1999; Schaeffer
et al., 2001) and postsynaptic localization of specific mRNAs
(Joe and Chakkalakal, 2003). Our results indicate that despite
the close proximity between the NMJ and the transcription\-
translation machinery, an ankB-based pathway is required for
accumulation of b-DG and dystrophin/utrophin at the postnatal
NMJ. Moreover, in the absence of ankB, the postnatal NMJ
resembled an immature neonatal-stage structure. Interestingly,
neonatal NMJs were morphologically normal in ankB null skele-
tal muscle. Thus ankB, dystrophin/utrophin, and b-DG all are
required for the maturation of the NMJ rather than in earlier
developmental stages.
b-DG is localized in a polarized pattern in nonmuscle tissues
including brain astrocytes where it is targeted to the glia limitans
at the cerebral spinal fluid-brain interface (Moore et al., 2002).
Interestingly, ankyrin-B/ mice have CNS defects, including
degeneration of the optic nerve and aplasia of the corpus cal-
losum (Scotland et al., 1998), that are similar to those observed
in muscle-eye-brain disease, which is associated with defective
glycosylation of dystroglycan (Brancaccio, 2005; Moore et al.,
2002). We found that the continuous linear compact staining
characteristic of b-DG in glia limitans in wild-type sections is re-
placed in ankyrin-B/ brain by diffuse staining throughout the
astrocytes (Figures S5A and S5B). Loss of localization of b-DG
to astrocyte endfeet is accompanied by infiltration of cell bodies
into cortical layer 1, where cell bodies are normally sparse
(Figure S5C). Moreover GFAP labeling reveals astrocytes
throughout the depth of the cortex, which are missing in wild-
type brain (Figure S5D). A similar marked increase in cortical
GFAP staining was described for brain b-DG knockout mice
(Moore et al., 2002). AnkB therefore is required for normal local-
ization of b-DG in astrocyte glia limitans as well as muscle cos-
tameres and NMJ.
We next addressed how ankyrins function as adaptors for
dystrophin and b-DG. Steady-state levels of dystrophin and
b-DG are maintained in ankB null neonatal skeletal muscle as
well as adult muscle depleted of ankB by siRNA. We did not
measure turnover of these proteins, so it is possible that
increased degradation is balanced by increased synthesis. How-
ever, a parsimonious interpretation is that the principal defect in
ankB-depleted muscle is in either delivery and/or retention of
dystrophin and b-DG at their sarcolemmal sites. We could not1198 Cell 135, 1189–1200, December 26, 2008 ª2008 Elsevier Inc.identify dystrophin in ankB-depleted muscle by immunofluores-
cence. We did find that b-DG accumulates in a juxta-TGN com-
partment in ankB-depleted muscle. Biochemical data indicate
that dystrophin can associate with both ankB and b-DG. How-
ever, we were not able to identify colocalization of these proteins
in an intracellular compartment. A major caveat in interpreting
these negative findings is that interactions may either be tran-
sient and/or not preserved under our fixation conditions.
We observed a subpopulation of microtubules associatedwith
costameres and the NMJ that disappeared in ankB-depleted
muscle. Interestingly, ankyrin-2 in Drosophila also has been
reported to stabilize presynaptic microtubules (Pielage et al.,
2008; Koch et al., 2008). These observations suggest that ankB
andankyrin-2determine long-rangeorganization ofmicrotubules
in addition to their established interactionswithmembrane-asso-
ciated proteins. Dystrophin-deficient mdx muscle fibers also
exhibit loss of costamere-associated microtubules (Percival
et al., 2007). Thus ankB and dystrophin, perhaps as a complex,
may both contribute to costamere-associated microtubules.
A clue as to how ankB could regulate microtubules comes
from our finding that ankB is a partner for dynactin-4 (dyn4/
p62). Dyn4/p62 is localized at the pointed end of dynactin arp1
filaments and has been proposed to link the microtubule motor
dynein to membrane cargo (Eckley et al., 1999; Schroer, 2004).
Dynactin is required for dynein function and promotes bidirec-
tional transport along microtubules (Ross et al., 2006; Schroer,
2004). Dynactin also functions in stabilizing the fast-growing
ends of microtubules at the plasma membrane (Shaw et al.,
2007). The coordinated loss of costamere-associated dyn4/
p62 and microtubules in ankB-depleted fibers suggest ankB
may be a membrane receptor for dynactin, which in turn stabi-
lizes microtubules.
Interestingly, b-spectrins also associate with dynactin through
arp1 (Holleran et al., 1996, 2001; Muresan et al., 2001). b-spec-
trins are well-established partners of ankyrins (Bennett and
Baines, 2001; Kizhatil et al., 2007) and also are components of
skeletal muscle costameres (Craig and Pardo, 1983; Nelson
and Lazarides, 1984; Vybiral et al., 1992). Moreover, b-spectrin
knockout in C. elegans causes major muscle breakdown (Moor-
thy et al., 2000). It is possible that ankB and b-2-spectrin collab-
orate in coordinating dynactin interactions with membrane
cargoes and/or docking sites for the fast-growing ends of micro-
tubules.
We hypothesize that ankB-dependent microtubules associ-
ated with costameres and the NMJ could provide the transport
route for newly synthesized b-DG, perhaps associated with
dystrophin, exiting from the trans-Golgi network. A similar direct
microtubule-based targeting has recently been suggested for
delivery of gap junction subunits to cadherin-based adhesion
sites in cardiomyocytes, where the ends of microtubules are
captured through interactions with the dynactin-complex sub-
unit p150glued (Shaw et al., 2007). This hypothesis immediately
raises questions for future studies regarding how ankB-based
cargo is sorted to the appropriate microtubule track, whether
ankB accompanies cargo during transport, and, most impor-
tantly, how ankB itself is targeted to costameres.
In summary, we present the evidence for a novel ankyrin-
dependent pathway for localizing the DGC to costameres and
the postnatal NMJ in skeletal muscle and to the glia limitans in
brain astrocytes. We propose a mechanism where an ankB-
dystrophin interaction is critical for targeting dystroglycan to
the sarcolemma by transport along costamere-associated
microtubules that are stabilized by ankB through its binding to
dyn4/p62 of the dynactin complex. We also show that ankG
binds to dystrophin and b-DG, and that ankG is required for
retention of these proteins at costameres. Further, we speculate
based on the phenotype of the ankB null mouse that a class of
muscle-eye-brain diseases in humans may result from failure in
this pathway for dystroglycan localization.
EXPERIMENTAL PROCEDURES
Molecular Biology
See detailed description of plasmids encoding siRNA, b-DG, dystrophin Dp71,
dynactin-4, ankB, and ankG as well as mutagenesis in the Supplemental Data.
Antibodies
Affinity-purified antibodies against ankB and ankG were previously described
(Kizhatil and Bennett, 2004; Scotland et al., 1998, respectively). AnkB antibody
was pre-absorbed on a purified ankG column and ankG antibody was pre-
absorbed on a purified ankB column to eliminate crossreactivity. b-DG rabbit
antibody (AP83) was a generous gift from Dr. Kevin P. Campbell, University of
Iowa. Affinity-purified rabbit and goat antibodies were prepared against the
b-DG cytoplasmic domain. An affinity-purified rabbit antibody was raised
against dynactin-4. For a list of all antibodies, see the Supplemental Data.
Muscle Tissue Preparations
AnkB knockout mice and their genotyping were described previously (Scot-
land et al., 1998). Muscles were snap-frozen in OCT in liquid nitrogen chilled
iso-pentane. Cross sections were fixed in 2% PFA, blocked (PBS, 4% BSA,
0.2% Tween 20), and permeabilized (blocking solution with 0.1% Triton
X-100). Sections were incubated at 4C overnight in primary antibodies and
2 hr with secondary antibodies.
In Vivo Transfections and Fiber Preparation
Briefly, tibialis anterior (TA) muscles of 3- to 4-week-old C57B\6 mice were
injected with 15U hyaluronidase (30 ml in saline) (Worthington; Lakewood,
NJ, USA) 2 hr prior to transfection (McMahon et al., 2001). TA muscles were
then injected with either siRNA or cDNA constructs depending on the experi-
ment and electroporated. For a detailed description, see the Supplemental
Data.
Exercise and EBD Experiments
Mice were treadmill exercised (LE 8706 Letica; Barcelona, Spain) twice a day
for 3 days (30 min, 10 uphill angle, 30 cm\s). Twelve hours before final
exercise, EBD (sigma; St. Louis, MO, USA) was injected IP (1 mg per 0.1 ml
per 10 g body weight). After the last running session TAmuscles were removed
for sectioning.
Microscopy and Imaging
Microscopy was performed with a Zeiss LSM510 Meta confocal microscope.
Three-dimensional reconstructions of Z stack images and voxel overlap
measurements were done with Velocity software (Improvision; Coventry,
England). EBD uptake in muscle sections was visualized using a 568 channel.
Statistical analysis was done with Origin 6.1 software (OriginLab; Northamp-
ton, MA, USA).
Binding Assays and Immunoblots
See detailed description in Supplemental Experimental Procedures.SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and
five figures and can be found with this article online at http://www.cell.com/
supplemental/S0092-8674(08)01309-3.
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